APA (7th ed.) Citation

Hamdi, A. I. F., Soon, H. H., Islam, M. K., Chee, J. W. L., & Stanslas, J. (2022). Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: Is it clinically relevant? Taylor and Francis.

Chicago Style (17th ed.) Citation

Hamdi, Amir Imran Faisal, Hin How Soon, Mohammad Kaisarul Islam, Jonathan Woei Lim Chee, and Johnson Stanslas. Adaptive Therapy to Circumvent Drug Resistance to Tyrosine Kinase Inhibitors in Cancer: Is It Clinically Relevant? Taylor and Francis, 2022.

MLA (9th ed.) Citation

Hamdi, Amir Imran Faisal, et al. Adaptive Therapy to Circumvent Drug Resistance to Tyrosine Kinase Inhibitors in Cancer: Is It Clinically Relevant? Taylor and Francis, 2022.